AnaptysBio's market cap is currently $1.01B. The company's EPS TTM is $-1.34; its P/E ratio is -8.08; AnaptysBio is scheduled to report earnings on August 6, 2025, and the estimated EPS forecast is $-1.21. See an overview of income statement, balance sheet, and cash flow financials.
